Torsemide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for torsemide and what is the scope of freedom to operate?
Torsemide
is the generic ingredient in three branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Norvium Bioscience, Sarfe Pharms, Aurobindo Pharma, Heritage, Hetero Labs Ltd Iii, Hikma, Pliva Pharm Ind, Strides Pharma, Sun Pharm Inds, and Teva, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Torsemide has two patent family members in two countries.
There are sixteen drug master file entries for torsemide. Twenty-one suppliers are listed for this compound.
Summary for torsemide
International Patents: | 2 |
US Patents: | 1 |
Tradenames: | 3 |
Applicants: | 13 |
NDAs: | 14 |
Drug Master File Entries: | 16 |
Finished Product Suppliers / Packagers: | 21 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Clinical Trials: | 23 |
Patent Applications: | 5,872 |
Drug Prices: | Drug price trends for torsemide |
Drug Sales Revenues: | Drug sales revenues for torsemide |
What excipients (inactive ingredients) are in torsemide? | torsemide excipients list |
DailyMed Link: | torsemide at DailyMed |
Recent Clinical Trials for torsemide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sarfez Pharmaceuticals, Inc. | Phase 2 |
Assiut University | Phase 4 |
Yale University | Phase 3 |
Pharmacology for torsemide
Drug Class | Loop Diuretic |
Physiological Effect | Increased Diuresis at Loop of Henle |
US Patents and Regulatory Information for torsemide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | TORSEMIDE | torsemide | TABLET;ORAL | 076226-003 | May 27, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva | TORSEMIDE | torsemide | TABLET;ORAL | 076110-004 | May 14, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hetero Labs Ltd Iii | TORSEMIDE | torsemide | TABLET;ORAL | 079234-003 | Jan 27, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for torsemide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | DEMADEX | torsemide | TABLET;ORAL | 020136-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Norvium Bioscience | DEMADEX | torsemide | TABLET;ORAL | 020136-004 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Norvium Bioscience | DEMADEX | torsemide | TABLET;ORAL | 020136-004 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for torsemide
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3065718 | FORMULATIONS À LIBÉRATION CONTRÔLÉE COMPRENANT DU TORSÉMIDE (CONTROLLED-RELEASE FORMULATIONS COMPRISING TORSEMIDE) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2015050570 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.